Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124508502 | 12450850 | 2 | F | 201604 | 20160725 | 20160609 | 20160907 | PER | US-JNJFOC-20160602579 | JANSSEN | 30.07 | YR | A | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124508502 | 12450850 | 1 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | N | 1513729P1 | 0 | MATRIX PATCH | ||||||||
| 124508502 | 12450850 | 2 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | N | 1513729P1 | 19813 | MATRIX PATCH | ||||||||
| 124508502 | 12450850 | 3 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 0 | 600 | MG | TABLET | QD | |||||||
| 124508502 | 12450850 | 4 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 400 | MG | CAPSULE | QID | |||||||
| 124508502 | 12450850 | 5 | C | MELOXICAM. | MELOXICAM | 1 | Oral | 0 | 7.5 | MG | TABLET | QD | |||||||
| 124508502 | 12450850 | 6 | C | HYDROCODONE | HYDROCODONE | 1 | Oral | 10-325 MG | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124508502 | 12450850 | 1 | Arthralgia |
| 124508502 | 12450850 | 2 | Back pain |
| 124508502 | 12450850 | 3 | Mental disorder |
| 124508502 | 12450850 | 4 | Mental disorder |
| 124508502 | 12450850 | 5 | Antiinflammatory therapy |
| 124508502 | 12450850 | 6 | Pain |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124508502 | 12450850 | Drug administered at inappropriate site | |
| 124508502 | 12450850 | Product adhesion issue | |
| 124508502 | 12450850 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124508502 | 12450850 | 1 | 201604 | 0 | ||
| 124508502 | 12450850 | 2 | 201604 | 0 | ||
| 124508502 | 12450850 | 4 | 2016 | 0 | ||
| 124508502 | 12450850 | 5 | 2015 | 0 | ||
| 124508502 | 12450850 | 6 | 2016 | 0 |